1. Home
  2. IGIC vs CMPX Comparison

IGIC vs CMPX Comparison

Compare IGIC & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International General Insurance Holdings Ltd.

IGIC

International General Insurance Holdings Ltd.

HOLD

Current Price

$23.82

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.72

Market Cap

926.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IGIC
CMPX
Founded
2001
2014
Country
Jordan
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
926.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IGIC
CMPX
Price
$23.82
$5.72
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$30.33
$13.44
AVG Volume (30 Days)
58.8K
2.5M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
4.42%
N/A
EPS Growth
N/A
N/A
EPS
2.81
N/A
Revenue
$525,808,999.00
N/A
Revenue This Year
$17.79
N/A
Revenue Next Year
$3.05
N/A
P/E Ratio
$8.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.82
$1.33
52 Week High
$27.76
$6.25

Technical Indicators

Market Signals
Indicator
IGIC
CMPX
Relative Strength Index (RSI) 41.81 58.06
Support Level $23.36 $5.09
Resistance Level $24.37 $6.25
Average True Range (ATR) 0.63 0.43
MACD -0.17 0.05
Stochastic Oscillator 25.54 64.04

Price Performance

Historical Comparison
IGIC
CMPX

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: